Inactive Instrument

InspireMD Inc Stock NYSE

US45779A5074

Medical Equipment, Supplies & Distribution

End-of-day quote NYSE Other stock markets
- ^USD	-

07-30	InspireMD, Inc. Appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	CI
07-24	InspireMD Receives Nasdaq Minimum Bid Price Warning	MT

Last Transcript: InspireMD Inc

InspireMD, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 04:20 PM

05-14

More transcripts

Analysts' recommendations: InspireMD Inc

12/06/23	Piper Sandler Initiates InspireMD at Overweight With $3 Price Target	MT
17/05/23	Alliance Global Adjusts Price Target on InspireMD to $4.75 From $5.15, Maintains Buy Rating	MT

More recommendations

Managers and Directors: InspireMD Inc

Manager	Title	Age	Since
Marvin Slosman CEO	Chief Executive Officer	62	01/01/2020
Michael Lawless DFI	Director of Finance/CFO	58	25/06/2025
Shany Barel CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Paul Stuka CHM	Chairman	71	02/06/2017
Michael Berman BRD	Director/Board Member	68	07/02/2013
Marvin Slosman BRD	Director/Board Member	62	01/01/2020

More insiders

InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	30.45M 26.47M 24.63M 22.62M 42.71M 2.91B 43.37M 290M 114M 1.45B 114M 112M 4.85B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	30.45M 26.47M 24.63M 22.62M 42.71M 2.91B 43.37M 290M 114M 1.45B 114M 112M 4.85B	EV / Sales 2026 *	2.93x	EV / Sales 2027 *	1.39x
Free-Float	80.17%	Yield 2026 *	-	Yield 2027 *	-

07-30	InspireMD, Inc. Appoints Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	CI
07-24	InspireMD Receives Nasdaq Minimum Bid Price Warning	MT
07-03	InspireMD, Inc. Announces Resignation of Raymond W. Cohen from Board and Committees, Effective July 1, 2026	CI
06-29	InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell 3000E Growth Benchmark	CI
06-29	InspireMD, Inc.(NasdaqCM:NSPR) dropped from Russell Microcap Growth Benchmark Index	CI
06-20	InspireMD, Inc. Announces Recalling Action on CGuard Prime Carotid Stent System 135Cm, 10Mmx30mm	CI
06-20	InspireMD, Inc. Announces Recalling Action for CGuard Prime Carotid Stent System 135cm, 10mmx40mm	CI
06-20	Inspiremd Inc Announces Recalling Action on Cguard Prime Carotid Stent System 135cm, 9mx30mm	CI
06-20	InspireMD, Inc. Announces Recalling of Cguard Prime Carotid Stent System 135Cm, 8Mmx30mm	CI
06-20	InspireMD Inc Announces Recalling Action For CGuard Prime Carotid Stent System 135cm, 8mmx40mm	CI
06-20	InspireMD, Inc. Announces Recalling Action for CGuard Prime Carotid Stent System 135 cm, 9 mx40mm	CI
06-08	Inspiremd Enrolls First Patient in Cguardians Iii Pivotal Study of Switchguard Neuro Protection System for Use in Tcar Procedures	CI
05-22	InspireMD, Inc. Announces Not Seek Re-Election of Paul Stuka as Director	CI

07-30	InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing	AQ
06-15	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	AQ
06-12	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	AQ
06-11	InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures	AQ
06-08	InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STRYKER CORPORATION	-6.42%	-1.38%	-13.79%	+16.63%	125B
SMITH & NEPHEW PLC	-2.48%	+1.62%	+0.17%	-1.53%	13.12B
GLAUKOS CORPORATION	-1.07%	+8.56%	+93.50%	+117.37%	9.83B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+1.11%	+10.55%	-40.93%	-66.58%	4.86B
DOUBLE MEDICAL TECHNOLOGY INC.	-2.28%	-0.67%	-3.31%	+33.83%	2.61B
ENOVIS CORPORATION	-0.51%	+7.84%	+13.25%	-54.26%	1.68B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+1.24%	+5.88%	-24.84%	-31.18%	1.68B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.60%	+5.00%	-14.81%	-19.18%	1.67B
Average	-1.23%	+3.05%	+1.15%	-0.61%	20.05B
Weighted average by Cap.	-5.26%	-0.18%	-6.57%	+17.46%

	2026 *	2027 *
Net sales	10.38M 9.02M 8.39M 7.71M 14.55M 990M 14.78M 98.95M 38.84M 493M 38.96M 38.11M 1.65B	21.92M 19.05M 17.73M 16.28M 30.74M 2.09B 31.22M 209M 82.03M 1.04B 82.31M 80.5M 3.49B
Net income	-	-
Net Debt	-	-

InspireMD Inc Stock NYSE

Stocks

US45779A5074

Medical Equipment, Supplies & Distribution

Valuation: InspireMD Inc

Latest news : InspireMD Inc

Last Transcript: InspireMD Inc

Analysts' recommendations: InspireMD Inc

Press Releases: InspireMD Inc

Managers and Directors: InspireMD Inc

Medical Devices & Implants

Financials

Company Profile